AkkoLens has successfully closed a new funding round, raising EUR 6.3 million from new and existing shareholders. The investor group includes specialised medtech funds, investors from the ophthalmic industry and private investors. The proceeds will be used to accelerate commercial growth and advance certification on international markets.

share this article

Other updates

July 2026

ETZ Tilburg adopts Lumina as a standard premium lens option

June 2026

Lumina resolves neuro-adaptation failure

May 2026

Eye centre Medipolis Antwerp begins commercial implantations

Get in
contact

Whether you have a question about the Lumina lens, our company or about the availability of the Lumina, our team will be happy to provide the information you need.

Eye care professional?

Looking for clinical information, product details or partnership opportunities? Explore our dedicated resources for healthcare professionals and industry partners.

For professionals

AkkoLens closes EUR 6.3 million funding round